Gabriela Rosu

Gabriela Nicola Rosu, MD joined Worldwide Clinical Trials as an Executive Director, Medical Affairs, Oncology. She provides medical monitoring for solid tumor and hematologic malignancy clinical trials, and consults with clients on protocol development, and offering strategies for optimal study delivery and risk mitigation. Gabriela also provides therapeutic and protocol training to study teams and mentors medical staff as requested.
Prior to joining Worldwide, Gabriela was a Senior Medical Director for Premier Research, a role in which she provided medical monitoring for oncology clinical trials in lymphoma, myeloma, and GU, GI, GYN, thoracic, melanoma, and CNS indications. Dr. Rosu has extensive experience with Immuno-oncology compounds including toxicity management.
Dr. Rosu served as Chief Medical Officer for IMV Inc for nearly four years, in which she had responsibility for oncology clinical development, KOL development, and planning for scientific publications and presentations at regional and national meetings. Prior to this, she was Global Medical Adviser /International Medical Director for Novo Nordisk Healthcare where she supported hemophilia and coagulation disorder clinical trials and Global Medical Affairs.
Gabriela graduated from the University of Medicine and Pharmacy Gr.T. Popa in Iasi, Romania, obtaining the Doctor in Medicine diploma. After completing her medical education, she worked as a physician in several hospitals in Iasi, Romania. More recently, Gabriela obtained a Certificate of Achievement from Harvard Medical School in Immunology and Immuno-Oncology.
Gabriela maintains active memberships for ASCO, ESMO and ACHE